Opposite Behaviors of Reactive Metabolites of Tienilic Acid and Its Isomer toward Liver Proteins: Use of Specific Anti-Tienilic Acid−Protein Adduct Antibodies and the Possible Relationship with Different Hepatotoxic Effects of the Two Compounds
- 20 February 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 12 (3) , 286-296
Abstract
Tienilic acid (TA) is responsible for an immune-mediated drug-induced hepatitis in humans, while its isomer (TAI) triggers a direct hepatitis in rats. In this study, we describe an immunological approach developed for studying the specificity of the covalent binding of these two compounds. For this purpose, two different coupling strategies were used to obtain TA−carrier protein conjugates. In the first strategy, the drug was linked through its carboxylic acid function to amine residues of carrier proteins (BSA−N−TA and casein−N−TA), while in the second strategy, the thiophene ring of TA was attached to proteins through a short 3-thiopropanoyl linker, the corresponding conjugates (BSA−S−5-TA and βLG−S−5-TA) thus preferentially presenting the 2,3-dichlorophenoxyacetic moiety of the drug for antibody recognition. The BSA−S−5-TA conjugate proved to be 30 times more immunogenic than BSA−N−TA. Anti-TA−protein adduct antibodies were obtained after immunization of rabbits with BSA−S−5-TA (1/35000 titer against βLG−S−5-TA in ELISA). These antibodies strongly recognized the 2,3-dichlorophenoxyacetic moiety of TA but poorly the part of the drug engaged in the covalent binding with the proteins. This powerful tool was used in immunoblots to compare TA or TAI adduct formation in human liver microsomes as well as on microsomes from yeast expressing human liver cytochrome P450 2C9. TA displayed a highly specific covalent binding focused on P450 2C9 which is the main cytochrome P450 responsible for its hepatic activation in humans. On the contrary, TAI showed a nonspecific alkylation pattern, targeting many proteins upon metabolic activation. Nevertheless, this nonspecific covalent binding could be completely shifted to a thiol trapping agent like GSH. The difference in alkylation patterns for these two compounds is discussed with regard to their distinct toxicities. A relationship between the specific covalent binding of P450 2C9 by TA and the appearance of the highly specific anti-LKM2 autoantibodies (known to specifically recognize P450 2C9) in patients affected with TA-induced hepatitis is strongly suggested.Keywords
This publication has 11 references indexed in Scilit:
- Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.Journal of Clinical Investigation, 1996
- Thiophene Sulfoxides as Reactive Metabolites: Formation upon Microsomal Oxidation of a 3-Aroylthiophene and Fate in the Presence of Nucleophilesin Vitroandin VivoChemical Research in Toxicology, 1996
- The Role of Covalent Binding to Microsomal Proteins in the Hepatotoxicity of AcetaminophenDrug Metabolism Reviews, 1995
- Specificity of in vitro Covalent Binding of Tienilic Acid Metabolites to Human Liver Microsomes in Relationship to the Type of Hepatotoxicity: Comparison with Two Directly Hepatotoxic DrugsChemical Research in Toxicology, 1994
- Human‐liver cytochromes P‐450 expressed in yeast as tools for reactive‐metabolite formation studiesEuropean Journal of Biochemistry, 1993
- Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes: Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylationBiochemical Pharmacology, 1991
- Oxidative activation of the thiophene ring by hepatic enzymesBiochemical Pharmacology, 1990
- Human Liver Mephenytoin 4 -Hydroxylase Cytochrome P-450 Proteins and GenesDrug Metabolism Reviews, 1989
- Cytochrome P-450 Monooxygenase Activities in Human and Rat Liver MicrosomesEuropean Journal of Biochemistry, 1981
- Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagentBiochemical Journal, 1978